Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Michel Burnier
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age \> 18 years
Patients on hemodialysis since more than 3 months
Patients with secondary hyperparathyroidism treated with Cinacalcet-HCl at a stable dose (30mg/day or more) for at least 1 month before enrolment and indication to Cinacalcet-HCL therapy (iPTH in target values or over target values)
Patients with secondary hyperparathyroidism with indication to be treated with Cinacalcet-HCL (iPTH ≥ locally pre-defined targets). In this case, patients should be treated at least 1 month with stable dose Cinacalcet-HCL before enrolment
You may not be if
Intolerance to Cincalcet-HCL
Inability to understand the protocol
Mental diseases
Patients suffering from cancer or having a short life expectancy (\<6 months)
Patients planned for a parathyroidectomy
Patients having had a parathyroidectomy
Patient already enrolled in a Cinacalcet-HCL protocol
Symptomatic hypocalcaemia or total serum calcium \< 1.87 mmol/l
